Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Impairment of regulatory T cells in myasthenia gravis: studies in an experimental model.

Gertel-Lapter S, Mizrachi K, Berrih-Aknin S, Fuchs S, Souroujon MC.

Autoimmun Rev. 2013 Jul;12(9):894-903. doi: 10.1016/j.autrev.2013.03.009. Epub 2013 Mar 25. Review.

PMID:
23535156
2.

Regulatory T cell-based immunotherapies in experimental autoimmune myasthenia gravis.

Souroujon MC, Aricha R, Feferman T, Mizrachi K, Reuveni D, Fuchs S.

Ann N Y Acad Sci. 2012 Dec;1274:120-6. doi: 10.1111/j.1749-6632.2012.06844.x.

PMID:
23252906
3.

Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis.

Aricha R, Mizrachi K, Fuchs S, Souroujon MC.

J Autoimmun. 2011 Mar;36(2):135-41. doi: 10.1016/j.jaut.2010.12.001. Epub 2010 Dec 30.

PMID:
21193288
4.

Involvement of phosphodiesterases in autoimmune diseases.

Mizrachi K, Aricha R, Feferman T, Kela-Madar N, Mandel I, Paperna T, Miller A, Ben-Nun A, Berrih-Aknin S, Souroujon MC, Fuchs S.

J Neuroimmunol. 2010 Mar 30;220(1-2):43-51. doi: 10.1016/j.jneuroim.2009.12.012. Epub 2010 Jan 25.

PMID:
20100627
5.

The upstream open reading frame of the Arabidopsis AtMHX gene has a strong impact on transcript accumulation through the nonsense-mediated mRNA decay pathway.

Saul H, Elharrar E, Gaash R, Eliaz D, Valenci M, Akua T, Avramov M, Frankel N, Berezin I, Gottlieb D, Elazar M, David-Assael O, Tcherkas V, Mizrachi K, Shaul O.

Plant J. 2009 Dec;60(6):1031-42. doi: 10.1111/j.1365-313X.2009.04021.x.

6.

Suppression of experimental autoimmune myasthenia gravis by inhibiting the signaling between IFN-gamma inducible protein 10 (IP-10) and its receptor CXCR3.

Feferman T, Aricha R, Mizrachi K, Geron E, Alon R, Souroujon MC, Fuchs S.

J Neuroimmunol. 2009 Apr 30;209(1-2):87-95. doi: 10.1016/j.jneuroim.2009.01.021. Epub 2009 Feb 20.

PMID:
19232748

Supplemental Content

Loading ...
Support Center